Hangzhou Valued Medtech Co., Ltd.
PrivateLast Round
Strategic
May 13, 2026
Est. Valuation
$1.43B
Total Funding Raised
$266M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Hangzhou Valued Medtech Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Strategic round in May 2026.
Hangzhou Valued Medtech Co., Ltd. is a medical device company that specializes in the research, development, and manufacturing of laparoscopic surgical instruments and disposable medical consumables.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Valued Medtech Co., Ltd. Comparables
Compare Hangzhou Valued Medtech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Touchstone International Medical Science Co Ltd | 86% | |
| EziSurg Medical | 85% | |
| Victor Medical Instruments Co., Ltd. | 85% |
For institutional investors. Book with your work email.
Hangzhou Valued Medtech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 13, 2026 | ||||
| Series B | May 6, 2021 | ||||
| Series A | Apr 1, 2019 |
For institutional investors. Book with your work email.
Hangzhou Valued Medtech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCP Capital | Series B |
| Lake Bleu Capital | Series B |
| Boyuan Capital | Series A |
| Qiming Venture Partners | Series A, Series B |
| HongShan Capital Group (HSG) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 79% MoM.
- May 13, 2026
$108M raised, led by Venus Medtech.
For institutional investors. Book with your work email.
Hangzhou Valued Medtech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hangzhou Valued Medtech Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou Valued Medtech Co., Ltd. a public or private company?
Hangzhou Valued Medtech Co., Ltd. is a private company.
What is the current stock price of Hangzhou Valued Medtech Co., Ltd.?
Hangzhou Valued Medtech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou Valued Medtech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hangzhou Valued Medtech Co., Ltd. worth (valuation)?
Hangzhou Valued Medtech Co., Ltd.'s valuation is estimated at $1.4B based on funding round data.
Can I buy Hangzhou Valued Medtech Co., Ltd. stock?
Hangzhou Valued Medtech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hangzhou Valued Medtech Co., Ltd.'s last funding round?
Hangzhou Valued Medtech Co., Ltd.'s most recent funding round was Strategic on May 13, 2026.
Who are the main investors in Hangzhou Valued Medtech Co., Ltd.?
Key investors in Hangzhou Valued Medtech Co., Ltd. include DCP Capital, HongShan Capital Group (HSG).
Will Hangzhou Valued Medtech Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Valued Medtech Co., Ltd..
How can I track Hangzhou Valued Medtech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hangzhou Valued Medtech Co., Ltd.'s shares on secondary markets.